menu search

Analysts estimate rxo (rxo) to report a decline in earnings: what to look out for

RXO (RXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its...

October 31, 2023, 11:17 am

Squarespace (sqsp) reports next week: wall street expects earnings growth

Squarespace (SQSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in ...

October 31, 2023, 11:17 am

Henry schein (hsic) earnings expected to grow: should you buy?

Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in ...

October 31, 2023, 11:17 am

Choice hotels (chh) reports next week: wall street expects earnings growth

Choice Hotels (CHH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in ...

October 31, 2023, 11:17 am

Analysts estimate lci (lcii) to report a decline in earnings: what to look out for

LCI (LCII) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its<...

October 31, 2023, 11:17 am

Robinhood markets, inc. (hood) may report negative earnings: know the trend ahead of next week's release

Robinhood Markets, Inc. (HOOD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in ...

October 31, 2023, 11:17 am

Earnings preview: thoughtworks holding, inc. (twks) q3 earnings expected to decline

Thoughtworks Holding, Inc. (TWKS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in ...

October 31, 2023, 11:17 am

Surgery partners (sgry) earnings expected to grow: what to know ahead of next week's release

Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in ...

October 31, 2023, 11:17 am

Adc therapeutics sa (adct) may report negative earnings: know the trend ahead of next week's release

ADC Therapeutics SA (ADCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in ...

October 31, 2023, 11:17 am

Legalzoom (lz) reports next week: wall street expects earnings growth

LegalZoom (LZ) possesses the right combination of the two key ingredients for a likely earnings beat in its...

October 31, 2023, 11:17 am

Everlodge on the rise: can it match bitcoin and ethereum’s growth?

Everlodge (ELDG) is in its presale phase, yet showing potential to challenge the dominance of establish...

October 31, 2023, 11:14 am

Exxon alters top structure following executive sexual assault charges

Since successfully closing the $59.9bn merger with Pioneer Natural Gas, Exxon had its feelers out for a...

October 31, 2023, 11:09 am

Y-mabs to announce third quarter 2023 financial and operating results on november 13, 2023

NEW YORK, Oct. 31, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will...

October 31, 2023, 11:05 am

Clearside biomedical to report third quarter 2023 financial results and provide corporate update on monday, november 13, 2023

ALPHARETTA, Ga., Oct. 31, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the deliver...

October 31, 2023, 11:05 am

Usd/jpy – yen plummets despite boj tweak

BoJ tweaks YCC, maintains 1% upper limit Japanese yen sinks The Japanese yen is sharply lower on Tuesday following the Bank of Japan policy meeting. I...

October 31, 2023, 11:04 am

Macerich reports third quarter 2023 results

SANTA MONICA, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) — The Macerich Company (NYSE: MAC) has released its...

October 31, 2023, 11:04 am

Bioxcel therapeutics to report third quarter 2023 financial results on november 14, 2023

NEW HAVEN, Conn., Oct. 31, 2023 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intel...

October 31, 2023, 11:00 am

Spyglass pharma initiates phase i/ii clinical trial of its intraocular drug delivery platform

Phase I/II trial initiated to investigate innovative SpyGlass platform for the long-term delivery of bimatoprost in patients with glaucoma and visuall...

October 31, 2023, 11:00 am

Vans and north face owner gets slammed. but jim cramer likes new ceo's turnaround plan

Shares of troubled VF Corp (VFC) sank 9.5%, the morning after management withdrew its fiscal year reven...

October 31, 2023, 10:49 am

1 extraordinary growth stock to buy at a discount

Despite the recent struggles, Tesla remains a strong growth stock to consider adding to your portfolio. With i...

October 31, 2023, 10:46 am


Search within

Pages Search Results: